Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Articles by Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
Lp(a) HORIZON Shows Pelacarsen Lowers Lp(a) 78% But Not Cardiovascular Events
2
Cannabis Use Tied to Higher Odds of Stroke, Cardiovascular Disease
3
ZEUS: Ziltivekimab Fails to Reduce Cardiovascular Events in ASCVD and CKD
4
AHA 2026: Intensive Blood Pressure Control Reduces Events After Ischemic Stroke
5